

Xeloda can cost over $3,000 per cycle. Learn how to save with generic Capecitabine, discount cards, patient assistance programs, and other strategies in 2026.
Cancer treatment is stressful enough without worrying about whether you can afford your medication. If you've been prescribed Xeloda (Capecitabine), you may have experienced sticker shock when you learned the price. Brand-name Xeloda can cost $1,500 to $3,500 per 3-week cycle without insurance, and even with coverage, specialty tier copays and coinsurance can leave you paying hundreds of dollars out of pocket each month.
The good news: there are real ways to reduce what you pay. This guide covers every major savings option available to Xeloda patients in 2026 — from generic substitution and discount cards to patient assistance programs that can provide the medication for free.
Let's start with the baseline numbers so you know what you're working with:
These numbers make it clear: without some form of savings, Capecitabine is a serious financial burden for most patients.
The single biggest cost-saving move is to ensure you're receiving generic Capecitabine rather than brand-name Xeloda. Generic Capecitabine is FDA-approved, therapeutically equivalent, and typically 70–90% less expensive than the brand.
Most pharmacies will automatically substitute generic unless your prescriber has written "Dispense as Written" (DAW) or "Brand Medically Necessary." If you're being charged brand-name prices, ask your pharmacist whether they're dispensing generic Capecitabine. If not, ask your oncologist to update the prescription to allow generic substitution.
Generic Capecitabine is available in both 150 mg and 500 mg tablets from multiple manufacturers, including Teva, Mylan (Viatris), Accord Healthcare, and others.
Even if you don't have insurance, a free prescription discount card can significantly reduce what you pay at the pharmacy. These cards are not insurance — they negotiate discounted rates with pharmacies that you can access instantly.
Here are the most popular options for Capecitabine savings:
GoodRx is the most widely used prescription discount platform. Generic Capecitabine prices through GoodRx typically range from $150 to $400 per cycle, depending on your dose and pharmacy. Simply search for "Capecitabine" at goodrx.com, enter your dose and quantity, and compare prices at pharmacies near you.
SingleCare offers similar savings and is accepted at most major pharmacy chains. Check singlecare.com/prescription/capecitabine for current pricing in your area.
RxSaver by RetailMeNot compares prices across multiple discount card providers. Visit rxsaver.com and search for Capecitabine to see the lowest available price at nearby pharmacies.
Additional options include Optum Perks, BuzzRx, ScriptSave WellRx, and America's Pharmacy. Each card negotiates independently with pharmacies, so prices can vary. It's worth checking 2–3 cards to find the lowest price for your specific dose and pharmacy.
Pro tip: Prices can vary dramatically between pharmacies — even within the same zip code. A discount card might save you $50–$200 per fill just by switching to a pharmacy with a better negotiated rate.
If you're uninsured, underinsured, or facing financial hardship, patient assistance programs (PAPs) can provide Capecitabine for free or at a dramatically reduced cost.
Genentech, the manufacturer of brand-name Xeloda, offers free medication through the Genentech Patient Foundation to patients who:
Apply online at genentech-access.com or call 1-866-422-2377. If approved, brand-name Xeloda is provided at no cost, shipped directly to your home or doctor's office.
If you have commercial (private) insurance but face high out-of-pocket costs, Genentech's co-pay assistance program can reduce your copay for brand-name Xeloda. This program is not available to Medicare or Medicaid patients (federal healthcare program rules prohibit manufacturer copay assistance for government-insured patients).
The Patient Access Network (PAN) Foundation provides co-pay assistance for patients with various diagnoses, including those on oral anticancer medications. Grants are subject to fund availability. Check panfoundation.org to see if funds are currently open for your diagnosis.
HealthWell Foundation offers financial assistance for specialty medications, including oral chemotherapy. Visit healthwellfoundation.org to check eligibility and fund availability.
CancerCare provides limited financial assistance for treatment-related costs, including copays and transportation. Visit cancercare.org for application information.
PAF offers co-pay relief programs and insurance navigation services. They can help you understand your insurance benefits and connect you with financial assistance. Visit patientadvocate.org.
If you have insurance, there are several strategies to minimize your out-of-pocket costs:
Capecitabine is typically placed on a specialty tier, which may require 25–33% coinsurance rather than a flat copay. Understanding your plan's pharmacy benefit — including deductibles, out-of-pocket maximums, and specialty tier cost-sharing — helps you plan financially.
Most insurance plans require prior authorization for Capecitabine. Your oncologist's office should submit this as part of the prescribing process, but delays are common. Ask your oncology team to start the PA process as early as possible — ideally before your first fill — to avoid out-of-pocket costs from an unapproved claim.
Some plans require that oral oncology medications be filled through a designated specialty pharmacy. Using an out-of-network pharmacy may result in higher costs or denied claims. Check with your insurance company before filling to ensure you're using the right pharmacy.
Once you hit your plan's annual out-of-pocket maximum, your insurance covers 100% of eligible costs for the rest of the year. For patients on long-term Capecitabine therapy, you may hit this limit within the first few months, after which your medication becomes free through insurance.
Capecitabine prices vary significantly between pharmacies. Use GoodRx, SingleCare, or RxSaver to compare prices at multiple pharmacies before filling. Independent pharmacies sometimes offer lower prices than major chains for generic specialty medications.
If your insurance allows it, filling a 90-day supply (or the equivalent of multiple cycles) through a mail-order pharmacy may be cheaper on a per-dose basis than filling one cycle at a time.
Some states offer pharmaceutical assistance programs (SPAPs) for residents who meet income criteria. These programs can supplement Medicare Part D coverage or help uninsured patients. Contact your state's Department of Health or visit medicare.gov for a list of SPAPs.
Mark Cuban's Cost Plus Drugs (costplusdrugs.com) offers select generic medications at transparent, low prices. Check their site to see if generic Capecitabine is available through their platform.
Medicare patients face unique challenges because manufacturer copay assistance programs are generally not available to them. However, several options exist:
No one should have to choose between affording cancer treatment and paying their other bills. While Xeloda and Capecitabine aren't cheap, the combination of generic substitution, discount cards, and patient assistance programs can dramatically reduce — or even eliminate — your out-of-pocket costs. Start with the simplest steps: confirm you're getting generic Capecitabine, check prices on GoodRx or SingleCare, and apply to patient assistance programs if you qualify.
If you're also struggling to find Capecitabine in stock, use Medfinder to search for pharmacies with availability near you, and read our guide on how to find Xeloda in stock.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.